توثيق جمعية علم النفس الأمريكية APA (الطبعة السابعة)

Huang, Z., Wang, Y., Li, B., Xu, Y., Huang, G., Song, Y., . . . Li, S. (2024, August). Neoadjuvant BRAF and MEK inhibitor therapy elicits pathological complete response in stage IIIA non‐small cell lung cancer harboring BRAF V600E mutation: A case report. Thoracic Cancer.

توثيق أسلوب شيكاغو (الطبعة السابعة عشر)

Huang, Zhicheng, et al. "Neoadjuvant BRAF and MEK Inhibitor Therapy Elicits Pathological Complete Response in Stage IIIA Non‐small Cell Lung Cancer Harboring BRAF V600E Mutation: A Case Report." Thoracic Cancer Aug. 2024.

توثيق جمعية اللغة المعاصرة MLA (الإصدار التاسع)

Huang, Zhicheng, et al. "Neoadjuvant BRAF and MEK Inhibitor Therapy Elicits Pathological Complete Response in Stage IIIA Non‐small Cell Lung Cancer Harboring BRAF V600E Mutation: A Case Report." Thoracic Cancer, Aug. 2024.